Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
D334625-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $39.90 | |
D334625-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $100.90 | |
D334625-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $319.90 | |
D334625-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $558.90 |
a cholesterol acyltransferase-1 and -2 inhibitor
Synonyms | AKOS040754969 | Dibenzyl (2S)-2-[3-(3,4-dihydroxyphenyl)propanoylamino]butanedioate | SR-01000946735 | HMS3649L12 | CAY10485 | BDBM50151701 | SNEUAEKNRYBOTP-QFIPXVFZSA-N | Dibenzyl N-[3-(3,4-dihydroxyphenyl)propanoyl]-L-aspartate | 3,4-Dihydroxy hydrocinn |
---|---|
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | 3,4-dihydroxy Hydrocinnamic acid (L-Aspartic acid dibenzyl ester) amide inhibits human ACAT-1 and ACAT-2 (Acyl-Coenzyme A cyltransferase-1 and -2) equally with an IC|50|of about 60 μM. ACAT-1 and ACAT-2 catalyze the formation of long chain fatty acyl-coenzyme A and cholesterol esters from cholesterol, and may play a role in the development of atherosclerosis. This chemical inhibits human ACAT-1 and ACAT-2 with an IC50 values of 95 and 81 μM, respectively and also inhibits copper-mediated oxidation of low density lipoproteins by 91% at a concentration of 2 μM. |
pKa | pKa: 9.77 (Predicted) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | dibenzyl (2S)-2-[3-(3,4-dihydroxyphenyl)propanoylamino]butanedioate |
---|---|
INCHI | InChI=1S/C27H27NO7/c29-23-13-11-19(15-24(23)30)12-14-25(31)28-22(27(33)35-18-21-9-5-2-6-10-21)16-26(32)34-17-20-7-3-1-4-8-20/h1-11,13,15,22,29-30H,12,14,16-18H2,(H,28,31)/t22-/m0/s1 |
InChi Key | SNEUAEKNRYBOTP-QFIPXVFZSA-N |
Canonical SMILES | C1=CC=C(C=C1)COC(=O)CC(C(=O)OCC2=CC=CC=C2)NC(=O)CCC3=CC(=C(C=C3)O)O |
Isomeric SMILES | C1=CC=C(C=C1)COC(=O)C[C@@H](C(=O)OCC2=CC=CC=C2)NC(=O)CCC3=CC(=C(C=C3)O)O |
PubChem CID | 35026724 |
Molecular Weight | 477.5 |
Enter Lot Number to search for COA:
Solubility | Soluble in water (0.25 mg/ml at 25° C), ethanol (~ 20 mg/ml), DMSO (~ 20 mg/ml), DMF (~ 20 mg/ml), and 1: 3 solution of ethanol:PBS (pH 7.2) (~ 0.25 mg/ml). |
---|---|
Refractive Index | n20D1.61 (Predicted) |
Boil Point(°C) | ~727.6° C at 760 mmHg (Predicted) |